Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease por Beck, Tim N., Nicolas, Emmanuelle, Kopp, Meghan C., Golemis, Erica A.

Enlace del recurso

Another small molecule in the oncometabolite mix: L-2-Hydroxyglutarate in kidney cancer por Shim, Eun-Hee, Sudarshan, Sunil

Enlace del recurso

ARF: Connecting senescence and innate immunity for clearance por Kearney, Alper Y., Anchang, Benedict, Plevritis, Sylvia, Felsher, Dean W.

Enlace del recurso

Bioinformatics analysis of the serine and glycine pathway in cancer cells por Antonov, Alexey, Agostini, Massimiliano, Morello, Maria, Minieri, Marilena, Melino, Gerry, Amelio, Ivano

Enlace del recurso

Blocking the survival of the nastiest by HSP90 inhibition por Workman, Paul, Clarke, Paul A., Al-Lazikani, Bissan

Enlace del recurso

Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas por Martin-Castillo, Begoña, Lopez-Bonet, Eugeni, Cuyàs, Elisabet, Viñas, Gemma, Pernas, Sonia, Dorca, Joan, Menendez, Javier A.

Enlace del recurso

Cdk5 and Foxc2 – a new relationship in the lymphatic vasculature por Liebl, Johanna

Enlace del recurso

A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome por Arancio, Walter, Genovese, Swonild Ilenia, Bongiovanni, Lucia, Tripodo, Claudio

Enlace del recurso

Challenges and perspective of drug repurposing strategies in early phase clinical trials por Kato, Shumei, Moulder, Stacy L., Ueno, Naoto T., Wheler, Jennifer J., Meric-Bernstam, Funda, Kurzrock, Razelle, Janku, Filip

Enlace del recurso

Chronic inflammation: is it the driver or is it paving the road for malignant transformation? por Afrasiabi, Kambiz, Zhou, Yi-Hong, Fleischman, Angela

Enlace del recurso

Click chemistry, 3D-printing, and omics: the future of drug development por Kurzrock, Razelle, Stewart, David J.

Enlace del recurso

Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo por Sai, Sei, Wakai, Toshifumi, Vares, Guillaume, Yamada, Shigeru, Kamijo, Takehiko, Kamada, Tadashi, Shirai, Toshiyuki

Enlace del recurso

The combinatorial complexity of cancer precision medicine por Klauschen, Frederick, Andreeff, Michael, Keilholz, Ulrich, Dietel, Manfred, Stenzinger, Albrecht

Enlace del recurso

Conserved E2F mediated metastasis in mouse models of breast cancer and HER2 positive patients por Rennhack, Jonathan, Andrechek, Eran

Enlace del recurso

Damaged mitochondria in Fanconi anemia – an isolated event or a general phenomenon? por Pagano, Giovanni, Shyamsunder, Pavithra, Verma, Rama S., Lyakhovich, Alex

Enlace del recurso

Doxycycline and therapeutic targeting of the DNA damage response in cancer cells: old drug, new purpose por Peiris-Pagès, Maria, Sotgia, Federica, Lisanti, Michael P.

Enlace del recurso

Drug resistance in cancer: molecular evolution and compensatory proliferation por Friedman, Ran

Enlace del recurso

Dual mTORC1/C2 inhibitors: gerosuppressors with potential anti-aging effect por Sousa-Victor, Pedro, García-Prat, Laura, Muñoz-Cánoves, Pura

Enlace del recurso

Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approach por Peppicelli, Silvia, Bianchini, Francesca, Calorini, Lido

Enlace del recurso

Energy excess is the main cause of accelerated aging of mammals por Biliński, Tomasz, Paszkiewicz, Tadeusz, Zadrag-Tecza, Renata

Enlace del recurso